Manifold Bio, Roche Partner on AI-Driven Brain Drug Design
Partnership leverages Manifold’s AI-guided direct-to-vivo platform for Roche to create a number of novel brain-targeted therapeutic merchandise Collaboration to make the most of Manifold’s mDesign direct-to-vivo AI-guided drug discovery engine and tissue-targeting shuttle portfolio to create blood-brain barrier (BBB) shuttles for a number of brain-targeted therapeutic modalities Manifold to obtain $55 million upfront, with potential for…
